SHENZHEN, China, April 17, 2023 /PRNewswire/ — On April 18, 2023, U.S. time, ImmVira presented preclinical study results of CAR-T enabler oHSV product MVR-7011 through poster publication at the American Association for Cancer Research (“AACR”) annual meeting. Solid tumor has long been a…